Open access · US-GOV
via ClinicalTrials.gov Clinical trial
AVIGA3: Using an 'Automated Vision Assessment and Impairment Detection Through Gaze Analysis' Through a Longitudinal, Open-labelled, Randomized Clinical Trial to Monitor Recurrence of Aged-related Macular Degeneration in a Home-based Setting (Cohort 2.0).
Authors not listed
Tan Tock Seng Hospital · 2025
Abstract
Age-Macular Degeneration (AMD) is a common eye condition and a leading cause of vision loss among people age 50 and older. It causes damage to the macula, a small area near the centre of the retina needed for sharp, central vision. It is estimated that the prevalence of early and late AMD in Asian populations aged 40 to 79 were 6.8% and 0.56% respectively. Prevalence in white populations estimated from large population studies were 8.8% and 0.59% respectively. With the aging population and people living longer, these numbers will only increase. Hence, this study aims to develop a system to evaluate the AVIGA system through remote monitoring for disease recurrence of wet aged-related macular degeneration using eye gaze tracking.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-02 MST
Cite this
APA
Anonymous. (2025). AVIGA3: Using an 'Automated Vision Assessment and Impairment Detection Through Gaze Analysis' Through a Longitudinal, Open-labelled, Randomized Clinical Trial to Monitor Recurrence of Aged-related Macular Degeneration in a Home-based Setting (Cohort 2.0). <em>Tan Tock Seng Hospital</em>. https://clinicaltrials.gov/study/NCT07255859
Vancouver
Anonymous. AVIGA3: Using an 'Automated Vision Assessment and Impairment Detection Through Gaze Analysis' Through a Longitudinal, Open-labelled, Randomized Clinical Trial to Monitor Recurrence of Aged-related Macular Degeneration in a Home-based Setting (Cohort 2.0). Tan Tock Seng Hospital. 2025.
BibTeX
@misc{anon2025AVIGAU,
title = {AVIGA3: Using an 'Automated Vision Assessment and Impairment Detection Through Gaze Analysis' Through a Longitudinal, Open-labelled, Randomized Clinical Trial to Monitor Recurrence of Aged-related Macular Degeneration in a Home-based Setting (Cohort 2.0).},
author = {Anonymous},
journal = {Tan Tock Seng Hospital},
year = {2025},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Genaera Corporation 2004
Open access · US-GOV
A Safety and Efficacy Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular Degeneration
Community Eye Health Journal 2014
Open access · CC-BY
Age-related macular degeneration
Ophthalmologica 2021
Citation only
Age-Related Macular Degeneration: Pathophysiology, Management, and Future Perspectives
US Department of Veterans Affairs 2003
Open access · US-GOV
Home-based Exercise Via a Telecommunications System
Current Medicinal Chemistry 2019
Citation only
Pharmacological Advances in the Treatment of Age-related Macular Degeneration
Health and Quality of Life Outcomes 2006
Open access · CC-BY